Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Lifecore Biomedical Q1 EPS $(0.29) Beats $(0.30) Estimate, Sales $31.109M Beat $26.471M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:25pm
Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.30) by 4.92 percent. This is a 45.28 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $31.109 million which beat the analyst consensus estimate of $26.471 million by 17.52 percent. This is a 25.92 percent increase over sales of $24.705 million the same period last year.

Posted In: LFCR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist